Oak HC/FT related stories
All articles and analysis
Hack your health: Private equity investors eye high multiples in 'precision healthcare''A precision healthcare physician practice management group is likely starting in the 12x to 14x EBITDA range, a DTC business will see 15x to 18x,' Fifth Third's Christopher Dorn tells PE Hub.
Oak HC/FT Partners rolls out sixth fundOak HC/FT Partners closed its previous fund at $1.94 billion in July 2022.
Oak HC/FT-backed Reveleer acquires healthcare tech firm NovillusHeadquartered in Glendale, California, Reveleer is a value-based care technology platform.
Funds are cautiously optimistic about a rebound in exitsSome VCs believe deals between small and midsized companies will proceed smoothly but that large-scale M&A transactions will continue to be hampered by unclear anti-trust treatment in certain concentrated markets.
- Justt lands $30m Series C
Zeev Ventures led the round with participation from existing investors Oak HC/FT and F2 Venture Capital.
Louisiana Teachers to commit up to $400m to VC next yearTRSL has already committed $50m to Insight Partners XIII, and it plans to invest as much as $350m more in four more VC funds in 2024.
VCJ 50: Extreme makeover editionWe refined our methodology to focus on capital raised for classic VC capital funds and didn’t include capital raised for growth equity.
LA City committed $135m to emerging managers in 2022The system has one of the nation’s oldest emerging manager programs.
Side Letter: TA's $16.5bn haul; VC's top-performing GPs; ESG family fortunesMonday is a bank holiday for our readers in the US, so we'll return to your inbox on Tuesday. In the meantime, TA Associates has beaten its target when many others are struggling to even meet theirs. Plus: venture capital's top-performing GPs. Here’s today's brief, for our valued subscribers only.
CalSTRS considers boosting PE targetThe nation’s second largest pension system sees potential for greater returns and adding to sustainable investing by increasing its allocation to private equity.